Biologics Contract Development and Manufacturing Organization(CDMO) Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
- 99S4166077
- 109 Pages
- January 2021
- Diagnostic and Biotech
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Biologics Contract Development and Manufacturing Organization(CDMO) market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Biologics Contract Development and Manufacturing Organization(CDMO) market segmented into
Biologics Contract Development Services
Biologics Contract Manufacturing Services
Based on the end-use, the global Biologics Contract Development and Manufacturing Organization(CDMO) market classified into
Big Pharma
Small Pharma
Generic Pharma
Others
Based on geography, the global Biologics Contract Development and Manufacturing Organization(CDMO) market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Lonza
Hansen
Boehringer Ingelheim BioXcellence
Thermo Fisher Scientific
Samsung BioLogics
AGC Biologics
Catalent
Wuxi Biologics
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL BIOLOGICS CONTRACT DEVELOPMENT AND MANUFACTURING ORGANIZATION(CDMO) INDUSTRY
2.1 Summary about Biologics Contract Development and Manufacturing Organization(CDMO) Industry
2.2 Biologics Contract Development and Manufacturing Organization(CDMO) Market Trends
2.2.1 Biologics Contract Development and Manufacturing Organization(CDMO) Production & Consumption Trends
2.2.2 Biologics Contract Development and Manufacturing Organization(CDMO) Demand Structure Trends
2.3 Biologics Contract Development and Manufacturing Organization(CDMO) Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Biologics Contract Development Services
4.2.2 Biologics Contract Manufacturing Services
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Big Pharma
4.3.2 Small Pharma
4.3.3 Generic Pharma
4.3.4 Others
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Biologics Contract Development Services
5.2.2 Biologics Contract Manufacturing Services
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Big Pharma
5.3.2 Small Pharma
5.3.3 Generic Pharma
5.3.4 Others
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Biologics Contract Development Services
6.2.2 Biologics Contract Manufacturing Services
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Big Pharma
6.3.2 Small Pharma
6.3.3 Generic Pharma
6.3.4 Others
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Biologics Contract Development Services
7.2.2 Biologics Contract Manufacturing Services
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Big Pharma
7.3.2 Small Pharma
7.3.3 Generic Pharma
7.3.4 Others
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Biologics Contract Development Services
8.2.2 Biologics Contract Manufacturing Services
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Big Pharma
8.3.2 Small Pharma
8.3.3 Generic Pharma
8.3.4 Others
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Biologics Contract Development Services
9.2.2 Biologics Contract Manufacturing Services
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Big Pharma
9.3.2 Small Pharma
9.3.3 Generic Pharma
9.3.4 Others
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Lonza
10.1.2 Hansen
10.1.3 Boehringer Ingelheim BioXcellence
10.1.4 Thermo Fisher Scientific
10.1.5 Samsung BioLogics
10.1.6 AGC Biologics
10.1.7 Catalent
10.1.8 Wuxi Biologics
10.2 Biologics Contract Development and Manufacturing Organization(CDMO) Sales Date of Major Players (2017-2020e)
10.2.1 Lonza
10.2.2 Hansen
10.2.3 Boehringer Ingelheim BioXcellence
10.2.4 Thermo Fisher Scientific
10.2.5 Samsung BioLogics
10.2.6 AGC Biologics
10.2.7 Catalent
10.2.8 Wuxi Biologics
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.Table Biologics Contract Development and Manufacturing Organization(CDMO) Product Type Overview
2.Table Biologics Contract Development and Manufacturing Organization(CDMO) Product Type Market Share List
3.Table Biologics Contract Development and Manufacturing Organization(CDMO) Product Type of Major Players
4.Table Brief Introduction of Lonza
5.Table Brief Introduction of Hansen
6.Table Brief Introduction of Boehringer Ingelheim BioXcellence
7.Table Brief Introduction of Thermo Fisher Scientific
8.Table Brief Introduction of Samsung BioLogics
9.Table Brief Introduction of AGC Biologics
10.Table Brief Introduction of Catalent
11.Table Brief Introduction of Wuxi Biologics
12.Table Products & Services of Lonza
13.Table Products & Services of Hansen
14.Table Products & Services of Boehringer Ingelheim BioXcellence
15.Table Products & Services of Thermo Fisher Scientific
16.Table Products & Services of Samsung BioLogics
17.Table Products & Services of AGC Biologics
18.Table Products & Services of Catalent
19.Table Products & Services of Wuxi Biologics
20.Table Market Distribution of Major Players
21.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
22.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
23.Table Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast (Million USD) by Region 2021f-2026f
24.Table Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast (Million USD) Share by Region 2021f-2026f
25.Table Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast (Million USD) by Demand 2021f-2026f
26.Table Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Forecast (Million USD) Share by Demand 2021f-2026f
Similar Reports
Biomaterials are materials of either synthetic or natural origin that are used for interaction with biological systems for medical purposes such as treating or repairing damage tissues. They are used in joint replacements, plastic surgeries, drug delivery devi...
- Publish Date: September 1, 2016
- $5370
The global DNA sequencing market was estimated to be $6,243 million in 2017 and is projected to reach $25,470 million in 2025 growing with a CAGR of 19% from 2018 to 2025. DNA sequencing is a type of technology in which several DNA strands can be sequenced through massive parallelization. The DNA sequencing contains both Sanger’s method of sequencing and non-Sanger’s methods of sequencing. ...
- Publish Date: May 24, 2017
- $5370
Patients with serious nervous system injuries or strokes often require lifelong assistance, which burdens patients, their families, and society. Innovative, paradigm shifting strategies are required to develop treatments for neurological injury. Early dia...
- Publish Date: May 24, 2017
- $5370
